- Adjunct Professor Bryan Day, QIMR Berghofer
- Lachlan Harris, QIMR Berghofer
Aims and Methodology
Glioblastoma (GBM) is the most common and malignant primary brain tumour in adults. GBM is deadly because of resistant glioma stem cells that reconstitute the tumour after treatment. Glioma stem cells resist chemotherapy in part because they are quiescent (slow-dividing), whereas chemotherapy primarily targets fast-dividing cells. In this project we will test targeted molecules to inhibit quiescence, forcing glioma stem cells to divide during chemotherapy to prevent tumour recurrence.
Applicants can expect to gain experience in tissue culture, microscopy, data analysis and to deepen their understanding of brain cancers.
Location of Research
QIMR Berghofer (Herston)
Laboratory experiments, Data collection, Data analysis
Skills and experience
Applicants who are enthusiastic about the project and have a good academic record. Experience in a research setting preferred but not required.
Resources / Access
Supervision and training, lab space, computer desk
Contact the supervisor for more information: email@example.com
firstname.lastname@example.org. Adjunct Professor Bryan Day is the principal supervisor.